McKesson sells minority stake in surgical supplies unit to Apollo Funds for $1.25 billion

McKesson will sell a minority stake in its medical-surgical solutions business to Apollo Funds for $1.25 billion as it moves toward spinning off the unit via an IPO. The transaction highlights meaningful monetization of the business ahead of separation and may support valuation discovery for the planned public listing. The news is constructive for McKesson, though the immediate impact is likely company-specific rather than broad market-moving.

Analysis

McKesson will sell a minority stake in its medical-surgical solutions business to Apollo Funds for $1.25 billion as it moves toward spinning off the unit via an IPO. The transaction highlights meaningful monetization of the business ahead of separation and may support valuation discovery for the planned public listing. The news is constructive for McKesson, though the immediate impact is likely company-specific rather than broad market-moving.